Neural Transplantation in Huntington's Disease: The NEST-UK Donor Tissue Microbiological Screening Program and Review of the Literature

2006 ◽  
Vol 15 (4) ◽  
pp. 279-294 ◽  
Author(s):  
M. Farrington ◽  
T. G. Wreghitt ◽  
A. M. L. Lever ◽  
S. B. Dunnett ◽  
A. E. Rosser ◽  
...  
Author(s):  
R. L. M. Faull ◽  
H. J. Waldvogel ◽  
L. F. B. Nicholson ◽  
M. N. Williams ◽  
M. Dragunow

1996 ◽  
Vol 5 (2) ◽  
pp. 339-352 ◽  
Author(s):  
Kathleen M. Shannon ◽  
Jeffrey H. Kordower

Huntington's disease (HD) is a neurodegenerative disorder affecting motor function, personality, and cognition. This paper reviews the experimental data that demonstrate the potential for transplantation of fetal striatum and trophic factor secreting cells to serve as innovative treatment strategies for HD. Transplantation strategies have been effective in replacing lost neurons or preventing the degeneration of neurons destined to die in both rodent and nonhuman primate models of HD. In this regard, a logical series of investigations has proven that grafts of fetal striatum survive, reinnervate the host, and restore function impaired following excitotoxic lesions of the striatum. Furthermore, transplants of cells genetically modified to secrete trophic factors such as nerve growth factor protect striatal neurons from degeneration due to excitotoxicity or mitochondrial dysfunction. Given the disabling and progressive nature of HD, coupled with the absence of any meaningful medical therapy, it is reasonable to consider clinical trials of neural transplantation for this disease. Fetal striatal implants will most likely be the first transplant strategy attempted for HD. This paper describes the variable parameters we believe to be critical for consideration for the design of clinical trials using fetal striatal implants for the treatment of HD.


PLoS Currents ◽  
2012 ◽  
Vol 4 ◽  
pp. e4f8606b742ef3 ◽  
Author(s):  
Oliver Quarrell ◽  
Kirsty L O'Donovan ◽  
Oliver Bandmann ◽  
Mark Strong

2001 ◽  
Vol 16 (8) ◽  
pp. 439-445 ◽  
Author(s):  
P. Naarding ◽  
H.P.H. Kremer ◽  
F.G. Zitman

SummaryA review was made of the literature on Huntington’s disease, including the clinical neurology, recent advances in pathophysiology and genetic mechanisms and psychopathology. It can be concluded that research on the latter is scarce, although the subject is relevant because of the co-occurrence of psychiatric, neurological and genetic phenomena, which may lead to novel concepts in the understanding of brain function. So far, attempts to provide a comprehensive and pragmatic description of the psychopathology of Huntington’s disease have been disappointing, probably due to the limitations of the DSM classification system in this disorder. Future research should focus not only on this classification system, but also on neuropsychological functioning, because of the degenerative nature of the disease. Systematic and controlled studies should be performed on the treatment of psychiatric abnormalities in Huntington’s disease before any conclusions can be drawn.


1999 ◽  
Vol 8 (1) ◽  
pp. 143-151 ◽  
Author(s):  
Marc S. Hurlbert ◽  
Rocio I. Gianani ◽  
Cynthia Hutt ◽  
Curt R. Freed ◽  
Farida G. Kaddis

Sign in / Sign up

Export Citation Format

Share Document